P133: Comparison of accuracy between faecal immunochemical test and faecal calprotectin for predicting mucosal healing in quiescent ulcerative colitis patients: a prospective multi-centre study
ECCO '19 Copenhagen
2019
P134: Long-term bowel function and fate of the ileal pouch after restorative proctocolectomy in patients with Crohn’s disease: a systematic review and meta-analysis
ECCO '19 Copenhagen
2019
P135: Altered body composition profiles in young adults with childhood-onset inflammatory bowel disease
ECCO '19 Copenhagen
2019
P136: Association between histological indices and ulcerative colitis activity measures among patients in the HICKORY (etrolizumab) open-label induction cohort
ECCO '19 Copenhagen
2019
P137: Serum biomarkers of degradation and formation of type III, IV and V collagen are associated with disease activity in patients with Crohn’s disease
ECCO '19 Copenhagen
2019
P138: Prediction model to safely cease anti-TNF therapy in Crohn’s disease: individual patient data meta-analysis (IPD-MA)
ECCO '19 Copenhagen
2019
P139: Advance of medical therapies may improve outcome of ulcerative colitis with cytomegalovirus infection
ECCO '19 Copenhagen
2019
P141: Faecal calprotectin correlates to UCEIS and can predict short-term recurrence in patients with ulcerative colitis
ECCO '19 Copenhagen
2019
P142: Ulcerative colitis: risk factors for relapse in clinical remission patients
ECCO '19 Copenhagen
2019
P143: Measuring the mediating effects of tofacitinib on health status in ulcerative colitis: data from the OCTAVE programme
ECCO '19 Copenhagen
2019
P144: Correlation between clinical, endoscopic, histological activity scores in a cohort of patients with ulcerative colitis: a prospective study
ECCO '19 Copenhagen
2019
P145: Telephone straight-to-test (tSTT) improves early diagnosis of inflammatory bowel disease (IBD)
ECCO '19 Copenhagen
2019
P147: Thromboembolic complications in patients with Inflammatory bowel disease predict poor prognosis: a large North Indian cohort study
ECCO '19 Copenhagen
2019
P149: Searching for bile acid malabsorption using serum fibroblast growth factor 19 (FGF19) and faecal bile acids in patients with inflammatory bowel diseases, microscopic colitis and irritable bowel syndrome
ECCO '19 Copenhagen
2019
P152: Fatty liver disease in IBD patients as a part of extraintestinal manifestations
ECCO '19 Copenhagen
2019